[1] Kim, H.T. and A.L. Goldberg, UBL domain of Usp14 and other proteins stimulates proteasome activities and protein degradation in cells
[J]. Proceedings of the National Academy of Sciences of the United States of America, 2018,115(50):E11642 -E11650.

[2] Liao Y, Xia X, Liu N, Cai J, Guo Z, Li Y, Jiang L, Dou QP, Tang D, Huang H, Liu J. Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
[J]. Oncogene, 2018 ,37(14):1896 -1910. 

[3] Liao Y, Liu N, Hua X, Cai J, Xia X, Wang X, Huang H, Liu J. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
[J]. Cell Death Dis, 2017 ,8(2):e2585. 

[4] 杜雪花,张晓东. USP14及其抑制剂调控肿瘤的发生与发展
[J]. 中国生物化学与分子生物学报,2021,37(10): 1297 -1304.

[5] Sha B, Chen X, Wu H, Li M, Shi J, Wang L, Liu X, Chen P, Hu T, Li P. Deubiquitylatinase inhibitor b-AP15 induces c-Myc-Noxa-mediated apoptosis in esophageal squamous cell carcinoma
[J]. Apoptosis, 2019 ,24(9-10):826-836. 

[6] Huang G, Li L, Zhou W. USP14 activation promotes tumor progression in hepatocellular carcinoma
[J]. Oncol Rep, 2015,34(6):2917-2924. 

[7] Wu N, Liu C, Bai C, Han YP, Cho WC, Li Q. Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of β-catenin
[J]. Int J Mol Sci, 2013 ,14(6): 10749-10760. 

[8] Wang Y, Wang J, Zhong J, et al. Ubiquitin-specific protease 14 (USP14) regulates cellular proliferation and apoptosis in epithelial ovarian cancer
[J]. Med Oncol, 2015 ,32(1):379. 

[9] Yang Y, Hou JQ, Qu LY, et al.
[Differential expression of USP2, USP14 and UBE4A between ovarian serous cystadenocarcinoma and adjacent normal tissues]
[J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2007 ,23(6):504-506. 

[10] Ji J, Lv J, Lv M, et al. USP14 regulates heme metabolism and ovarian cancer invasion through BACH1 deubiquitination and stabilization
[J]. Biochem Biophys Res Commun, 2023 ,667:186-193. 

[11] Luo H, Wang X, Ge H, et al. Inhibition of ubiquitin‑specific protease 14 promotes connexin 32 internalization and counteracts cisplatin cytotoxicity in human ovarian cancer cells
[J]. Oncol Rep, 2019 ,42(3):1237-1247. 

[12] Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2019. CA: a cancer journal for clinicians, 2019. 69(1): p. 7-34.

[13] Vogel RI, Pulver T, Heilmann W, et al. USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment
[J]. Oncotarget, 2016 , 7(21): 30962-30976. 

[14] 苏英杰,曾凯,赵越,等. USP14全长及截短表达质粒构建及其在子宫内膜癌中功能的初探
[J]. 解剖科学进展, 2021,27(4):385-388,392. 

[15] Gupta A, Shah K, Oza MJ, et al. Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment
[J]. Biomed Pharmacother, 2019 ,109:484-492. 

[16] Lee G, Oh TI, Um KB, et al. Small-molecule inhibitors of USP7 induce apoptosis through oxidative and endoplasmic reticulum stress in cancer cells
[J]. Biochem Biophys Res Commun, 2016 ,470(1):181-186. 

[17] Zhang W, Sartori MA, Makhnevych T, et al. Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10
[J]. J Mol Biol,2017 ,429(22):3546-3560. 

[18] Lee BH, Lee MJ, Park S, et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14
[J]. Nature, 2010 ,467(7312):179-184. 

[19] Xu L, Wang J, Yuan X, et al. IU1 suppresses proliferation of cervical cancer cells through MDM2 degradation
[J]. Int J Biol Sci, 2020,16(15):2951-2963.